Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarrs Group Regulatory News (CARR)

Share Price Information for Carrs Group (CARR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 131.00
Bid: 131.00
Ask: 134.00
Change: -2.00 (-1.50%)
Spread: 3.00 (2.29%)
Open: 133.00
High: 133.00
Low: 131.00
Prev. Close: 133.00
CARR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Animax Limited

21 Sep 2018 07:00

RNS Number : 4794B
Carr's Group PLC
21 September 2018
 

 

 

 

 

 

CARR'S GROUP PLC ("Carr's" or the "Group")

Acquisition of Animax Limited

Carr's Group bolsters its position in animal health with key acquisition

 

 

21 September 2018: Carr's (CARR.L), the Agriculture and Engineering Group, announces the acquisition of the entire issued share capital of Animax Limited ("Animax"), a producer of market-leading animal health products, for a total cash consideration of up to £8.5m.

 

Animax, based in Suffolk in the UK, was established in 1982. The business specialises in the research, development and manufacture of highly effective animal health products. Animax is at the forefront of innovation in the field of livestock trace element supplementation. Its patent-protected leaching boluses, currently sold in the UK and overseas under the Tracesure® and Allsure® brands, are specifically designed to deliver health benefits to livestock consistently over prolonged periods.

 

Animax also produces other leading animal health and trace element supplementation products sold under well-known brands including Copasure®, Copinox®, Coprac®, Easycal®, Pardevit® and Paracide®.

 

Highlights and strategic rationale of the acquisition:

 

The acquisition of Animax aligns with the Group's stated strategy of investing in growing agriculture markets in the UK and internationally.

 

In particular, Animax and its product ranges:

 

· enhance the Group's position in the global animal health and livestock supplementation markets;

· bring innovation and patent-protected technology to the Group together with a number of recognised and highly respected brands;

· are highly complementary to, and will benefit from clear synergies with, the established Carr's Group feed block business across the USA, NZ, Europe, UK and Ireland; and

· broaden the Group's animal health and supplementation product ranges which bring added value to farmers.

 

Carr's will support the growth and development of Animax through investment in research to develop new products and by investing in manufacturing efficiencies. In addition, Carr's expects significant manufacturing, distribution and sales synergy benefits to be realised as a result of the acquisition.

 

As part of the acquisition, Carr's has also acquired the entire issued share capital of Animax's related party, Clinimax Limited ("Clinimax"). Clinimax is a manufacturer of specialist disinfectant products for use in the medical industry and which also carry the benefit of patent-protection.

 

Both businesses are being acquired for an initial cash consideration of £6m, with an additional cash consideration of up to a maximum of £2.5m payable over the period to November 2020, based on the achievement of agreed financial targets.

 

For the year ended 30 November 2017, Animax and Clinimax in aggregate recorded EBITDA of £0.6m and profit before tax of £0.3m. The combined gross assets of Animax and Clinimax as at 30 November 2017 totalled £5.6m, including cash of £1.2m. The acquisition is expected to be earnings enhancing in the first full year of ownership. The total consideration is being satisfied by the Group's existing facilities.

 

Tim Davies, Chief Executive, commented:

 

"We are delighted to announce the acquisition of Animax. This acquisition is in line with our stated strategy of developing our offering in the growing livestock specialist nutrition market both in the UK and internationally. Animax is highly complementary to our global feed block business and will add value to our customers' businesses. Animax has a history of developing market leading products based on sound research with their brands being recognised for their efficacy and performance. The combination of Carr's resources, knowledge and distribution, together with the Animax research capability, product technology and history of innovation, make a compelling case for this strategic step for the Group."

 

 

 

 

Enquiries:

Carr's Group plc

Tim Davies (Chief Executive)

Neil Austin (Group Finance Director)

 

Tel: +44 (0) 1228 554 600

Powerscourt

Nick Dibden / Lisa Kavanagh / Sam Austrums

 

Tel: +44 (0) 20 7250 1446

 

About Carr's Group plc:

Carr's is an international leader in manufacturing value added products and solutions, with market leading brands and robust market positions in Agriculture and Engineering, supplying customers in over 50 countries around the world.

Its Agriculture division manufactures and supplies feed blocks and supplementation products for livestock, distributes farm machinery and runs a UK network of rural stores, providing a one-stop shop for the farming community. Its Engineering division designs and manufactures bespoke equipment and provides technical engineering services into the nuclear, petrochemical, oil and gas, pharmaceutical, process and renewable energy industries, including robotic and remote handling equipment.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQGMGZLGGKGRZZ
Date   Source Headline
2nd Mar 201811:10 amRNSDirector/PDMR Shareholding
1st Feb 20184:40 pmRNSSecond Price Monitoring Extn
1st Feb 20184:35 pmRNSPrice Monitoring Extension
31st Jan 20184:40 pmRNSSecond Price Monitoring Extn
31st Jan 20184:35 pmRNSPrice Monitoring Extension
9th Jan 20185:08 pmRNSAGM Result
9th Jan 20187:00 amRNSTrading Update
8th Jan 20184:35 pmRNSPrice Monitoring Extension
5th Jan 20184:40 pmRNSSecond Price Monitoring Extn
5th Jan 20184:35 pmRNSPrice Monitoring Extension
22nd Dec 201712:39 pmRNSDirector/PDMR Shareholding
22nd Dec 20177:00 amRNSDirector/PDMR Shareholding
15th Dec 201710:52 amRNSBlock listing Six Monthly Return
28th Nov 20174:05 pmRNSDirector/PDMR Shareholding
28th Nov 20174:00 pmRNSDirector/PDMR Shareholding
13th Nov 20177:00 amRNSFinal Results
31st Oct 201712:30 pmRNSTotal Voting Rights
8th Sep 20177:00 amRNSUpdate on Board Committees
10th Aug 20172:31 pmRNSHolding(s) in Company
7th Aug 20177:00 amRNSCarr's Group acquires NuVision Engineering, Inc.
20th Jul 20177:00 amRNSTrading Statement
27th Jun 20179:07 amRNSHolding(s) in Company
14th Jun 20172:54 pmRNSBlock Listing Six Monthly Return
12th Apr 20177:00 amRNSHalf-year Report
30th Mar 20177:00 amRNSTrading Update
20th Mar 20173:42 pmRNSHolding(s) in Company
17th Mar 20173:28 pmRNSHolding(s) in Company
6th Mar 20174:02 pmRNSBlock listing Six Monthly Return
2nd Mar 201711:44 amRNSDirector/PDMR Shareholding
28th Feb 20172:27 pmRNSTotal Voting Rights
31st Jan 20173:21 pmRNSTotal Voting Rights
11th Jan 20171:00 pmRNSResult of AGM
10th Jan 20177:00 amRNSTrading Update
6th Dec 20167:00 amRNSCompany Secretary Change
29th Nov 20162:01 pmRNSTotal Voting Rights
25th Nov 201611:12 amRNSDirector/PDMR Shareholding
22nd Nov 20163:55 pmRNSHolding(s) in Company
16th Nov 20163:38 pmRNSDirector/PDMR Shareholding
16th Nov 20163:30 pmRNSDirector/PDMR Shareholding
16th Nov 20163:26 pmRNSDirector/PDMR Shareholding
14th Nov 20167:00 amRNSFinal Results
25th Oct 201612:33 pmRNSAcquisition of STABER GmbH
14th Oct 20169:57 amRNSHolding(s) in Company
29th Sep 201610:57 amRNSTotal Voting Rights
15th Sep 20164:58 pmRNSDirector/PDMR Shareholding
15th Sep 20164:56 pmRNSDirector/PDMR Shareholding
13th Sep 201611:18 amRNSDirector/PDMR Shareholding
5th Sep 20167:00 amRNSDisposal of Food Division and Return of Capital
30th Aug 20162:43 pmRNSTotal Voting Rights
10th Aug 20164:03 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.